A Round-Up on the Opioid Epidemic
Jan 30, 2019 • 3 min read
The growing awareness of the toll opioid consumption is taking on the US population had a substantial boost last week with accusations of failure to address the public health problem coming from within the FDA. The head of the agency's opioid advisory committee stated it had failed to learn its lessons and keeps approving strong opioid painkillers, thus putting the interests of big pharma ahead of public health. In the meantime, concern comes from every side of public life: from the Senate, who sent a letter to the FDA’s commissioner showing atonement towards the fact they keep approving new medication, to Walgreen's board of investors, who required the company to show how it's monitoring and managing risks related to the opioid crisis. The world is starting to acknowledge how big a problem we have between our hands.